the year 2024 within the period specified by the Capital Market Supervisory Board which is within April 4, 2025. However, JCT submitted form 56-1 One Report for the year 2024 to the SEC on April 8, 2025
followings, Sales For Q2’2017, total sales revenue of the company was Baht 3,463 million, increased by 5.5% or Baht 180 million from Q2’2016, which had total sales revenue of Baht 3,283 million due to increase
quarter ended 31 March 2019 which had been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners of the Company for Q1/2019 in
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.064/2018 14 May 2018 Subject : Explanation of the change in operating results of Q1/2018 which exceed
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.106/2018 8 August 2018 Subject : Explanation of the change in operating results of Q2/2018 which
Limited and its subsidiaries (“the company”) would like to clarify the operating results for the second quarter 2017 which have been reviewed and duly approved by the Board of Directors. For the second
million as compared to the same period last year due largely to the following: The overall revenue from hotel operations which comprise of hotel, golf and retail operations decreased by Baht 52 million
of the Company’s business operation in the year of 2019 is as follows; 1. Total incomes and Gross profit The Company had total incomes in the amount of Baht 321.29 million which decreases in the amount
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.158/2018 12 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.172/2018 30 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which